Skip to content

Drug interactions

Leflunomide + Ublituximab

Severity: Major

Leflunomide and Ublituximab: major interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Both drugs suppress immune function, so combined use may increase the risk of serious infections. The risk is greater because leflunomide's active metabolite persists for a long time.

What this interaction means in plain words

Leflunomide and Ublituximab can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for.

Leflunomide belongs to Musculoskeletal; Ublituximab belongs to Miscellaneous.

Evidence level: Moderate

Why it happens

Additive immunosuppression from B-cell depletion by ublituximab and lymphocyte antiproliferation by leflunomide.

What to do

Avoid combining where possible. If used together, monitor closely for infection, and consider the long persistence of teriflunomide, using accelerated elimination if needed.

What to ask your pharmacist

  • Does the benefit of taking both outweigh the risk in my case?
  • Do I need any blood test, ECG or other check while on both?
  • What early warning signs should I watch for, and what should I do if they appear?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Leflunomide and Ublituximab, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 14 days on the web. No card needed.

Frequently asked questions

Can I take Leflunomide with Ublituximab?

MediHelp rates the interaction as major. Leflunomide and Ublituximab can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for. Both drugs suppress immune function, so combined use may increase the risk of serious infections. The risk is greater because leflunomide's active metabolite persists for a long time.

How serious is the interaction between Leflunomide and Ublituximab?

MediHelp rates it major, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Avoid combining where possible. If used together, monitor closely for infection, and consider the long persistence of teriflunomide, using accelerated elimination if needed.

What other medicines interact with Leflunomide?

MediHelp also lists interactions of Leflunomide with, for example, Bcg vaccine live, Influenza virus vaccine quadrivalent intranasal, Measles mumps and rubella vaccine live. The full list is on the Leflunomide page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in